Publicação: Effects of the application of α1- and α2-adrenoceptor agonists and antagonists into the ventromedial hypothalamus on the sodium and potassium renal excretion
dc.contributor.author | Saad, W. A. | |
dc.contributor.author | Camargo, L. A A | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-26T21:57:47Z | |
dc.date.available | 2014-05-26T21:57:47Z | |
dc.date.issued | 1984-01-01 | |
dc.description.abstract | The effects of sodium and potassium excretion after intrahypothalamic administration of two α-adrenoceptor agonists and the effect of α-adrenoceptor antagonists were studied in groups of rats. Prazosin was equally effective at blocking the natriuretic and kaliuretic responses to the α1-adrenoceptor agonist phenylephrine and the mixed α1/α2-adrenoceptor agonist noradrenaline, while yohimbine which acts preferentially on α2-adrenoceptors was effective in potentiating these responses. These results suggest the presence of two types of α-adrenoceptors for the modulation of ventromedial hypothalamic pathways that interfere with the regulation of the two cations: stimulation of α1-adrenoceptors facilitates, while stimulation of α2-adrenoceptors inhibits the excretion of the ions. | en |
dc.format.extent | 228-234 | |
dc.identifier | http://dx.doi.org/10.1159/000137967 | |
dc.identifier.citation | Pharmacology, v. 28, n. 4, p. 228-234, 1984. | |
dc.identifier.doi | 10.1159/000137967 | |
dc.identifier.issn | 0031-7012 | |
dc.identifier.scopus | 2-s2.0-0021362154 | |
dc.identifier.uri | http://hdl.handle.net/11449/63648 | |
dc.language.iso | eng | |
dc.relation.ispartof | Pharmacology | |
dc.relation.ispartofjcr | 1.538 | |
dc.relation.ispartofsjr | 0,502 | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Scopus | |
dc.subject | alpha 1 adrenergic receptor | |
dc.subject | alpha 2 adrenergic receptor | |
dc.subject | alpha adrenergic receptor stimulating agent | |
dc.subject | noradrenalin | |
dc.subject | phenylephrine | |
dc.subject | prazosin | |
dc.subject | yohimbine | |
dc.subject | animal experiment | |
dc.subject | central nervous system | |
dc.subject | kidney | |
dc.subject | nonhuman | |
dc.subject | potassium urine level | |
dc.subject | rat | |
dc.subject | sodium urine level | |
dc.subject | zona incerta | |
dc.subject | Adrenergic alpha-Agonists | |
dc.subject | Adrenergic alpha-Antagonists | |
dc.subject | Animal | |
dc.subject | Dogs | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Hypothalamus, Middle | |
dc.subject | Norepinephrine | |
dc.subject | Phenylephrine | |
dc.subject | Potassium | |
dc.subject | Prazosin | |
dc.subject | Rabbits | |
dc.subject | Rats | |
dc.subject | Sodium | |
dc.subject | Support, Non-U.S. Gov't | |
dc.subject | Yohimbine | |
dc.title | Effects of the application of α1- and α2-adrenoceptor agonists and antagonists into the ventromedial hypothalamus on the sodium and potassium renal excretion | en |
dc.type | Artigo | |
dcterms.license | http://www.karger.com/Services/RightsPermissions | |
dspace.entity.type | Publication |